id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-N-0452-0003,FDA,FDA-2003-N-0452,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Certain Biologics Labeling,Notice,Notice of Approval,2004-03-09T05:00:00Z,2004,3,,,2025-03-12T20:01:58Z,04-5192,0,0,09000064804a25d3
FDA-2003-N-0452-0002,FDA,FDA-2003-N-0452,Supporting Statement - Certain Biologics Labeling,Supporting & Related Material,Background Material,2004-03-09T05:00:00Z,2004,3,,,2025-07-25T16:33:42Z,,0,0,09000064804a25d2
FDA-2003-N-0452-0001,FDA,FDA-2003-N-0452,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Certain Biologics
Labeling",Notice,60 Day Proposed Information Collection,2003-11-07T05:00:00Z,2003,11,2003-10-31T05:00:00Z,2003-12-02T04:59:59Z,2025-03-12T19:49:21Z,03-27389,0,0,09000064804a25cb